The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Tribovax T

Intervet Ireland LimitedVPA10996/260/001

Main Information

Trade NameTribovax T
Active SubstancesC. chauvoei
C. haemolyticum
C. haemolyticum cells
C.noyvi B
C. noyvi B cells
C.septicum CN3204 (3U/ml)
C.septicum CN368(7U/ml)
Dosage FormSuspension for injection
Licence HolderIntervet Ireland Limited
License Holder AddressMagna Drive
Magna Business Park, Citywest Road
Dublin 24
Licence NumberVPA10996/260/001

Group Information

ATC CodeQI02AB01 clostridium
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued14/01/2005
Legal StatusLR: Licensed Retailer as defined in national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back